Giorgio Sesti

Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): Recommendations from Italian scientific societies, patient associations and regulators

Effect of Periodontal Treatment on Metabolic Syndrome Parameters: A Systematic Review

ITA-MASLD: A national observational study to characterize the profile of patients with MASLD in specialistic care in Italy

International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes

Influenza vaccination for elderly, vulnerable and high-risk subjects: a narrative review and expert opinion

Current diagnostic criteria identify risk for type 2 diabetes too late

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes

LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals

Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes

Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes

Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI)

Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis

Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care

Correspondence on ‘Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis‘

Review of methods for detecting glycemic disorders

Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect

Comparative effectiveness of dapagliflozin vs <scp>DPP</scp>‐4 inhibitors on a composite endpoint of <scp>HbA1c</scp>, body weight and blood pressure reduction in the real world

Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus

The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method

Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation

Dulaglutide is an effective treatment for lowering HbA1c in patients with type 2 diabetes regardless of body mass index

Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose ≥ 155 mg/dl (8.6 mmol/L)

The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents

Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Management of diabetes in older adults

Mechanisms linking empagliflozin to cardiovascular and renal protection

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes)

Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice